Skip to content

Clinical trials

Phase 1/2 Anemia, Refractory trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory Phase: Phase 1/2 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20031
20051
20061
20091
20101

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center2
Masonic Cancer Center, University of Minnesota2
Case Comprehensive Cancer Center1
Drexel University College of Medicine1
National Cancer Institute (NCI)1
Stanford University1
Traws Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory9
Leukemia, Myeloid, Acute7
Myelodysplastic Syndromes7
Anemia, Refractory, with Excess of Blasts6
Leukemia, Myelomonocytic, Chronic6
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Leukemia4
Lymphoma, Non-Hodgkin4
Myeloproliferative Disorders4
Blast Crisis3

Trials

Showing 76 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.